Biobanking Market - Growth Opportunity, Share and Forecast


Posted October 24, 2019 by roberthenric

The Biobanking Market is expected to reach $2.69 billion, at a CAGR of 7.8%.

 
The Market Research Report on Biobanking, Considering useful aspects like; Application, Sample Type — Global Future Forecast, published by MarketsandMarkets™.

Factors driving the growth of this Biobanking Market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research; and the growing need for cost-effective drug discovery and development.

The equipment segment is estimated to account for the largest share of the market. This is primarily attributed to the increasing number of biobanks and rising number of bio samples around the world, due to which the demand for equipment remains high.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594

The Biobanking Market report provides insights on the following pointers:

Biobanking Penetration: Comprehensive information on the product portfolios of the top players in the biobanking market

Biobanks Market Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the biobanks.

Biobanking Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the market

Biobanking Development: Comprehensive information about emerging markets. This report analyzes the market for various biobanking products across geographies

Biobanks Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biobanking market

Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=594

Regenerative medicine applications for biobanking will drive the market

Biobanking Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the market.

Major Biobanking Market Developments

In 2017, Brooks Automation, Inc. (U.S.) launched BioStore IIIv, BioStudies Biobank Data Management, FluidX, IntelliXcap Decapper systems to strengthen its product portfolio in biobanking segment.

In 2016, Thermo Fisher Scientific Inc. (U.S.) entered into a partnership with Hamilton Storage (U.S.) to strengthened Thermo Fisher’s presence in the market.

In 2015, Panasonic Healthcare Holdings (Japan) launched MDF-DU900V VIP -86°C Upright Freezer.

Major Key Players Operating the Biobanking Market:

include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.).
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Phone 18886006441
Business Address marketsandmarkets
630 Dundee Road Suite 430 Northbrook, IL 60062 USA
Country United States
Categories Biotech
Tags biobanking market
Last Updated October 24, 2019